The Centers for Medicare & Medicaid Services (CMS) has delayed the new “two midnight” rule for Medicare hospital admissions until after Sept. 30, 2014.
A recent study conducted in Japan showed significant early post-administration improvements in sepsis patients who were given a single-dose administration of intravenous immune globulin (IVIG).
U.S. Health and Human Services announced $150 million in awards will be issued under the Affordable Care Act to support new full-time healthcenter delivery sites across the nation.
New research shows that women have a stronger immune response than men when given the flu vaccine, which may mean vaccinated women are better protected against catching the flu than vaccinated men.
Updates on CRA, Merk & Co., Pfizer, Amgen Inc., Incyte Corp., and more.
The U.S. Department ofHealth and Human Services announced $55.5 million in grants to support training for health professionals and bolster the size of the nation’s healthcare workforce.
Updates on clinical trials for vaccines against a protein believed to cause Alzheimer's, clostridium difficile and RSV.
Researchers at King’s College London have identified a new gene, PIM1, which could be an effective target for innovative treatments and therapies for psoriasis, an autoimmune disease.
A new study conducted by the Centers for Disease Control and Prevention shows that the number of childhood vaccines administered, either in a single day or during the first two years of life, has no bearing on autism risk.
A Canadian study showed that pregnant women who are vaccinated against the flu are significantly less likely to deliver premature or low-birth-weight babies compared with unvaccinated expectant mothers.
DiaVacs’ type 1 diabetes therapy DV-0100 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA).
A new international study has found that vaccines may prevent the risk of strokes in children.
